Concert Pharmaceuticals, Inc. Restricted Cash, Noncurrent
Concert Pharmaceuticals, Inc. had Restricted Cash, Noncurrent of $1.16 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2022-11-07
- 2022-09-30: Restricted Cash, Noncurrent $1.16M.
- 2022-06-30: Restricted Cash, Noncurrent $1.16M.
- 2022-03-31: Restricted Cash, Noncurrent $1.16M.
- 2021-12-31: Restricted Cash, Noncurrent $1.16M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2022-09-30 | $1.16M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.16M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $1.16M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $1.16M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $1.16M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $1.16M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.16M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $1.16M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $1.16M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $1.16M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.16M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $1.16M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $1.16M 10-Q · filed 2020-04-30 |
| 2018-12-31 | $1.16M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.56M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $1.56M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $1.56M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $1.56M 10-K · filed 2019-02-28 |